Berrada M, Kolenda C, Tristan A, Laurent F, et al. Could oritavancin be a promising alternative treatment for staphylococcal bone and joint infections? Insights from the determination of oritavancin minimum inhibitory concentrations in a collection of clinical isolates from the French National referen Eur J Clin Microbiol Infect Dis 2026 Jan 6. doi: 10.1007/s10096-025-05383.
PMID: 41493744